These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

450 related articles for article (PubMed ID: 29885802)

  • 81. Generation and evaluation of an H9N1 influenza vaccine derived by reverse genetics that allows utilization of a DIVA strategy for control of H9N2 avian influenza.
    Wu R; Chen Q; Zheng L; Chen J; Sui Z; Guan Y; Chen Z
    Arch Virol; 2009; 154(8):1203-10. PubMed ID: 19543688
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Vaccines developed for H5 highly pathogenic avian influenza in China.
    Qiao C; Tian G; Jiang Y; Li Y; Shi J; Yu K; Chen H
    Ann N Y Acad Sci; 2006 Oct; 1081():182-92. PubMed ID: 17135510
    [TBL] [Abstract][Full Text] [Related]  

  • 83. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Consequence of Cryptosporidiosis on the immune response of vaccinated broiler chickens against Newcastle disease and/or avian influenza.
    Eladl AH; Hamed HR; Khalil MR
    Vet Res Commun; 2014 Sep; 38(3):237-47. PubMed ID: 24993748
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Oral administration of live attenuated Salmonella enterica serovar Typhimurium expressing chicken interferon-α alleviates clinical signs caused by respiratory infection with avian influenza virus H9N2.
    Rahman MM; Uyangaa E; Han YW; Kim SB; Kim JH; Choi JY; Yoo DJ; Hong JT; Han SB; Kim B; Kim K; Eo SK
    Vet Microbiol; 2011 Dec; 154(1-2):140-51. PubMed ID: 21764226
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.
    Rauw F; Palya V; Gardin Y; Tatar-Kis T; Dorsey KM; Lambrecht B; van den Berg T
    Avian Dis; 2012 Dec; 56(4 Suppl):913-22. PubMed ID: 23402112
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Humoral antibody responses to different H5N1 and H5N2 vaccination regimes: implications for the development of autogenously based vaccines.
    Shany SA; El-Kady MF; Eid BT; Hassan ER; Abdel-Moneim AS
    Vet Microbiol; 2011 Dec; 153(3-4):398-402. PubMed ID: 21752557
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Protective avian influenza in ovo vaccination with non-replicating human adenovirus vector.
    Toro H; Tang DC; Suarez DL; Sylte MJ; Pfeiffer J; Van Kampen KR
    Vaccine; 2007 Apr; 25(15):2886-91. PubMed ID: 17055126
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Immunogenicity and protective efficacy of a multivalent herpesvirus vectored vaccine against H9N2 low pathogenic avian influenza in chicken.
    Ingrao F; Ngabirano E; Rauw F; Dauphin G; Lambrecht B
    Vaccine; 2024 May; 42(15):3410-3419. PubMed ID: 38641498
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Conserved T-cell epitopes of respiratory syncytial virus (RSV) delivered by recombinant live attenuated influenza vaccine viruses efficiently induce RSV-specific lung-localized memory T cells and augment influenza-specific resident memory T-cell responses.
    Matyushenko V; Kotomina T; Kudryavtsev I; Mezhenskaya D; Prokopenko P; Matushkina A; Sivak K; Muzhikyan A; Rudenko L; Isakova-Sivak I
    Antiviral Res; 2020 Oct; 182():104864. PubMed ID: 32585323
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Induction of immune response in chickens primed in ovo with an inactivated H9N2 avian influenza virus vaccine.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    BMC Res Notes; 2018 Jul; 11(1):428. PubMed ID: 29970157
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Mucosally administered Lactobacillus surface-displayed influenza antigens (sM2 and HA2) with cholera toxin subunit A1 (CTA1) Induce broadly protective immune responses against divergent influenza subtypes.
    Li R; Chowdhury MY; Kim JH; Kim TH; Pathinayake P; Koo WS; Park ME; Yoon JE; Roh JB; Hong SP; Sung MH; Lee JS; Kim CJ
    Vet Microbiol; 2015 Sep; 179(3-4):250-63. PubMed ID: 26210951
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Chimeric Newcastle Disease Virus-like Particles Containing DC-Binding Peptide-Fused Haemagglutinin Protect Chickens from Virulent Newcastle Disease Virus and H9N2 Avian Influenza Virus Challenge.
    Xu X; Qian J; Qin L; Li J; Xue C; Ding J; Wang W; Ding W; Yin R; Jin N; Ding Z
    Virol Sin; 2020 Aug; 35(4):455-467. PubMed ID: 32274680
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Characterization of H5N2 influenza viruses isolated in South Korea and their influence on the emergence of a novel H9N2 influenza virus.
    Kim HR; Park CK; Oem JK; Bae YC; Choi JG; Lee OS; Lee YJ
    J Gen Virol; 2010 Aug; 91(Pt 8):1978-1983. PubMed ID: 20392898
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Establishment of memory CD8+ T cells with live attenuated influenza virus across different vaccination doses.
    Wang Z; Kedzierski L; Nuessing S; Chua BYL; Quiñones-Parra SM; Huber VC; Jackson DC; Thomas PG; Kedzierska K
    J Gen Virol; 2016 Dec; 97(12):3205-3214. PubMed ID: 27902386
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy of an inactivated bivalent vaccine against the prevalent strains of Newcastle disease and H9N2 avian influenza.
    Zhao J; Yang H; Xu H; Ma Z; Zhang G
    Virol J; 2017 Mar; 14(1):56. PubMed ID: 28302119
    [TBL] [Abstract][Full Text] [Related]  

  • 97. A Live Attenuated Influenza Vaccine Elicits Enhanced Heterologous Protection When the Internal Genes of the Vaccine Are Matched to Those of the Challenge Virus.
    Smith A; Rodriguez L; El Ghouayel M; Nogales A; Chamberlain JM; Sortino K; Reilly E; Feng C; Topham DJ; Martínez-Sobrido L; Dewhurst S
    J Virol; 2020 Jan; 94(4):. PubMed ID: 31748399
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Trend of Changes in the Titer of Antibody against Avian Influenza Virus H9n2 during Raising Period in Vaccinated and Unvaccinated Broiler Farms in Qazvin Province, Iran: A Cohort Study.
    Mirzaiee K; Shoushtari A; Bokaie S; Fallah Mehrabadi MH; Peighambari SM
    Arch Razi Inst; 2020 Mar; 75(1):9-16. PubMed ID: 32291997
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Dendritic cell-targeted recombinantLactobacilli induce DC activation and elicit specific immune responses against G57 genotype of avian H9N2 influenza virus infection.
    Sun Y; Qian J; Xu X; Tang Y; Xu W; Yang W; Jiang Y; Yang G; Ding Z; Cong Y; Wang C
    Vet Microbiol; 2018 Sep; 223():9-20. PubMed ID: 30173758
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Safety, immunogenicity and protection of A(H3N2) live attenuated influenza vaccines containing wild-type nucleoprotein in a ferret model.
    Korenkov DA; Laurie KL; Reading PC; Carolan LA; Chan KF; Isakova-Sivak II; Smolonogina TA; Subbarao K; Barr IG; Villanueva J; Shcherbik S; Bousse T; Rudenko LG
    Infect Genet Evol; 2018 Oct; 64():95-104. PubMed ID: 29929009
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.